血小板减少与血液中微粒的临床检验结果分析

  • 打印
  • 收藏
收藏成功


打开文本图片集

【摘要】目的:统计血小板减少与血液中微粒的临床检验结果。方法:对2018年5月—2020年7月阶段内的血栓性疾病128例患者纳入研究范围,并且选取同期体检的健康人员加以比较,检测接受检验的人员血小板微粒情况,研究检验最终结果。结果:冠心病患者、肾功能衰竭患者、脑梗死患者这几种疾病患者在处于静息状态下的血小板微粒释放量均大于健康人员微粒释放量(1.40±0.56)×105/mL(P0.05);健康人员在活化状态下微粒释放量均数(1.82±0.50)×105/mL,较静息状态下微粒释放量均数(1.40±0.74)×105/mL大(P

【关键词】血小板;血液;微粒;临床检验

Analysis of clinical test results of thrombocytopenia and particles in blood

LING Haiying

Wushan Hospital of traditional Chinese Medicine, Tianshui, Gansu 741306, China

【Abstract】Objective: to count the clinical test results of thrombocytopenia and particles in blood. Methods: 128 patients with thrombotic diseases from May 2018 to July 2020 were included in the study, and the healthy personnel who underwent physical examination in the same period were selected for comparison. The platelet particles of the personnel who underwent the examination were detected, and the final results were tested. Results: the release of platelet particles in patients with coronary heart disease, renal failure and cerebral infarction was greater than that in healthy people (1.40 ± 0.56)×105 /mL(P0.05); The average amount of particles released by healthy people in activated state (1.82±0.50)×105/ mL,compared with the mean particle release under resting state(1.40±0.74)×105/mL(P

【Key words】Platelet; Blood; Particles; Clinical test

血小板是机体骨髓成熟的巨核细胞胞质经过裂解脱落的产物,还是哺乳动物血液内生物活性的一种组成成分。(剩余3399字)

目录
monitor